Balance Sheet for Calithera Biosciences Inc. (CALA)

$ 3.7437 R     -0.3563 (-8.69%) Volume: 676.48k 3:49 PM EDT 20-Oct-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 60,437 51,058 48,475 10,601 6,105
Restrictable Cash - - - - -
Marketable Securities 96,924 85,095 115,318 41,180 63,823
Accounts Receivable 482 1,997 1,142 - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 482 1,997 1,142 - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 1,953 2,102 2,732 1,780 2,567
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 159,796 140,252 167,667 53,561 72,495
Land and Improvements - - - - -
Buildings and Improvement 1,234 1,234 1,232 326 326
Machinery, Furniture and Equipment 2,960 2,974 2,767 2,454 2,203
Construction in Progress - - - - -
Fixed Assets, Other 7,260 - - - -
Fixed Assets, Total 11,454 4,208 3,999 2,780 2,529
Gross Fixed Assets 11,454 4,208 3,999 2,780 2,529
Accumulated Depreciation (3,202) (2,744) (2,240) (1,881) (1,598)
Net Fixed Assets 8,252 1,464 1,759 899 931
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 720 1,009 668 336 327
Total Non-Current Assets 8,972 2,473 24,788 1,235 3,255
Total Assets 168,768 142,725 192,455 54,796 75,750
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 2,052 1,247 1,072 398 562
Short Term Debt 1,478 - - - -
Notes Payable - - - - -
Accrued Expenses 14,547 11,167 8,938 4,055 3,271
Accrued Liabilities 14,547 11,167 8,938 4,055 3,271
Deferred Revenues 1,547 2,467 29,017 - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - - -
Total Current Liabilities 19,624 14,881 39,027 4,453 3,833
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - 1,130 3,121 437 129
Other Non-Current Liabilities - 1,130 3,121 437 129
Minority Interest - - - - -
Capital Lease Obligations 6,718 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 6,718 1,130 3,121 437 129
Total Liabilities 26,342 16,011 42,148 4,890 3,962
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 142,426 126,714 150,307 49,906 71,788
Common Par 6 4 4 2 2
Additional Paid in Capital 428,479 322,993 300,906 172,419 156,353
Cumulative Translation Adjustments - - - - -
Retained Earnings (286,101) (196,170) (150,333) (122,502) (84,498)
Treasury Stock - - - - -
Other Equity Adjustments 42 (113) (270) (13) (69)
Total Capitalization 142,426 126,714 150,307 49,906 71,788
Total Equity 142,426 126,714 150,307 49,906 71,788
Total Liabilities & Shareholder's Equity 168,768 142,725 192,455 54,796 75,750
Cash Flow (89,442) (54,862) (28,637) (38,891) (33,494)
Working Capital 140,172 125,371 128,640 49,108 68,662
Free Cash Flow (78,752) (65,056) 12,522 (31,426) (30,374)
Invested Capital 142,426 126,714 150,307 49,906 71,788
Shares Outstanding - Common Class Only 63,514 38,834 35,759 21,502 18,232
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 63,514 38,834 35,759 21,502 18,232
Total Common Shares Outstanding 63,514 38,834 35,759 21,502 18,232
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 47,312 36,604 32,951 19,486 18,045
Diluted Weighted Shares Outstanding 47,312 36,604 32,951 19,486 18,045